Critical Contrast: Bullfrog AI (NASDAQ:BFRG) vs. Mobile-health Network Solutions (NASDAQ:MNDR)

Insider and Institutional Ownership

1.0% of Bullfrog AI shares are owned by institutional investors. 33.9% of Bullfrog AI shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Bullfrog AI and Mobile-health Network Solutions’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-195.35%	-162.37%
Mobile-health Network Solutions	N/A	N/A	N/A

Earnings & Valuation

This table compares Bullfrog AI and Mobile-health Network Solutions”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	N/A	N/A	-$6.99 million	($0.76)	-1.64
Mobile-health Network Solutions	$13.97 million	0.43	-$15.60 million	N/A	N/A

Bullfrog AI has higher earnings, but lower revenue than Mobile-health Network Solutions.

Volatility and Risk

Bullfrog AI has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500. Comparatively, Mobile-health Network Solutions has a beta of -2.59, suggesting that its stock price is 359% less volatile than the S&P 500.

Summary

Bullfrog AI beats Mobile-health Network Solutions on 4 of the 7 factors compared between the two stocks.

About Bullfrog AI

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.

About Mobile-health Network Solutions

Mobile-health Network Solutions, an investment holding company, provides telehealth solutions in Singapore. The company operates in two segments, Telemedicine and Other Services, and Sale of Medicine and Medical Devices. It offers MaNaDr platform, a 360-degree healthcare ecosystem, which connects users and service providers through the range of healthcare services and product offerings that can be accessed through the mobile application and website. The company also provides a range of primary healthcare services, including general medical consultations, treatment and management of acute and chronic conditions in adults and children, vaccinations, and health screenings for work permit applications, as well as pre-employment health screening, children's health services, geriatric care services, and minor surgical procedures. In addition, it offers healthcare and wellness-related products through its online e-commerce platform; wholesale distribution of pharmaceutical products to clinics; and MaNaCare, a platform that provides a range of corporate healthcare and wellness services, including GP, specialist and allied healthcare panel services, tele-consultation services, in-person clinics, on-site health screening, and online marketplace and forum, as well as wellness programs to corporate customers. Further, the company develops IT systems on mobile phone and web portals; operates pharmacies, clinics, and drug stores; and offers beauty and other personal care services, as well as other general medical and health services. The company was founded in 2009 and is headquartered in Singapore.